Article
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
PloS one - 1 Jan 2015
Asselah Tarik, Zeuzem Stefan, Soriano Vicente, Bronowicki Jean-Pierre, Lohse Ansgar W, Müllhaupt Beat, Schuchmann Marcus, Bourlière Marc, Buti Maria, Roberts Stuart K, Gane Edward J, Stern Jerry O, Voss Florian, Baum Patrick, Gallivan John-Paul, Böcher Wulf O, Mensa Federico J
Abstract excerpt
BACKGROUND & AIM: Whether inosine triphosphatase (ITPA) gene polymorphisms predict anemia during interferon-free therapy in chronic hepatitis C virus (HCV)-infected patients is unknown. We examined the relationship between two ITPA polymorphisms, anemia, and sustained virological response 12 weeks post-treatment (SVR12) in patients receiving the NS3/4A protease inhibitor faldaprevir, the non-nucleoside polymerase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
